Heather Mudrick Joins Workforce Genetics to Lead Clinical Search Practice
Theradaptive, Inc. received a $6.2 million infusion of cash from a Series A funding round that will be used to drive the company’s lead biologic asset, AMP2, into clinical trials next year.
Myeloid Therapeutics and MaxCyte Enter Clinical and Commercial Licensing Agreement to Advance Myeloid’s Cell Therapy ProgramsPublished on :
Patented high-performance cell-engineering platform to biopharmaceutical partners engaged in drug discovery and development, biomanufacturing and cell therapy, including gene editing and immuno-oncology.
The pandemic has caused the cancellations and delays of clinical trials, making it ever more challenging to effectively plan, design and execute clinical trials, especially for emerging companies.
Why does it take so long to develop vaccines? The current COVID-19 pandemic has raised questions about the logistics in creating a new vaccine. Some may be frustrated with the [….]
Four NIH COVID-19 Clinical Research Programs Launched to Combat the Pandemic The National Institutes of Health (NIH) has launched four clinical studies to advance the approval of new medicines for [….]
This Startup is on a Mission to Decentralize Cell and Gene Therapy Clinical Trials For the cell and gene therapy revolution to be fully realized, physicians, research scientists, biomanufacturing experts, [….]
Four Companies Using Big Data to Drive Innovation in Precision Medicine: A Recap of the 1st Digital Omics Innovators Meetup
Four Companies Using Big Data to Drive Innovation in Precision Medicine A Recap of the 1st Digital Omics Innovators Meetup By: Joelle Herman, Founder of NeoTrials, LLC An Executive Forum [….]